Pfizer Ex-Marketing Director Agrees To Injunction, Ending Trade Secret Suit
Executive Summary
Former Pfizer employee has joined Sun Pharma as it launches ophthalmic drug and expands its specialty portfolio, which includes Phase III monoclonal antibody for treatment of psoriasis.
You may also be interested in...
Patent Filing By Former Employees Leads Pfizer To File Trade Secret Suit
Pfizer claims two former employees stole trade secrets relating to its diabetes-obesity GLP-1 receptor agonist research program for their startup Regor Therapeutics. Regor’s $1.5bn deal with Lilly further spurred Pfizer’s concerns.
Employee’s Decoy Laptop Did Not Trick Pfizer Security, Trade Secret Suit Says
Pfizer alleges its associate director of statistics transferred 12,000 files from her company laptop ahead of move to Xencor. Company seeks a temporary restraining order to prevent her from disclosing confidential information, including information on Pfizer’s COVID-19 vaccine and monoclonal antibodies for treatment of cancer.
Par Alleges 'Shocking' Trade Secret Theft By QuVa Pharma
Par says former employees who founded QuVa used Par's trade secrets to develop a vasopressin product, which FDA has added to its list of ingredients for drug compounding.